top read note buysid
import report jefbio
jefferi top most-read note april includ seri note
remdesivir aacr planner preview takeaway call patent
lawyer discuss amrn vascepa trial appeal analysi
great crisi also highlight addit report contain
uniqu view worth revisit insid full tabl april note
remdesivir sentiment consist w/ view apr
new remdesivir data interest impt data week apr
remdesivir manufactur ramp prepar apr
industri go preview planner apr
detail niaid studi consist effect apr
remd studi posit hit primari efficaci endpoint apr
amrn patent expert think chanc win appeal year apr
rem-d mix data probabl benefit modest apr
industri happen biopharma biz apr
amrn quick updat flag court eu regulatori meet apr
eun yang key report vaccin report vaccin expert discuss
summar overview potenti advantag challeng associ select
approach vaccin develop variou modal employ
vaccin develop expert seem excit mrna approach
potenti potenc scalabl initi efficacy/immunogen
vaccin candid mrna vaccin data late summer expert see
rise total antibodi coronaviru spike protein benchmark success
seri call oncolog kol gain insight util til
therapi kol cervic cancer set clinic bar orr dor til
go-to-ag set also predict iova til therapi applic
advanc cervic cancer patient real world link second kol provid posit
feedback util til select set cancer stress durabl efficaci
key clinic bar front-lin set cancer link
moffitt til trial nsclc report compel data two durabl
link link invit expert express respons impress
two complet respons w/ durabl close year rare come
pop expert cite would like longer follow-up patient trial
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
link collect kol see broad util iova til therapi view
name given pivot data catalyst
insid addit comment team
pleas see import disclosur inform page report
ahead expect approv august conduct poll us eu hematologist
gaug data expect potenti valrox util poll show stabil
efficaci year vs yr durabl import price faster uptak
vs current expect market uptak valrox vosoritid approv could
faster current market drug drive stronger growth
expect top-lin revenu rise vs profit margin expans vs
investor call management set expect two expect
dataset cours like drive share provid first
glimps platform first data present
hope see sign efficaci clinic respons cell kinet data
provid insight pot durabl link
conduct analysi factor could influenc pbo respons
roluperidon ph studi found studi site fewer eu site tend
lead higher pbo respons think stringent ph studi inclus conduct
criteria could moder degre pbo effect continu lean posit
top-line piii data due believ june link also host kol call
state moa roluperidon could address diseas biolog effect size
primari ep ph studi state clinic meaning need
educ doctor outsid academ center id ing pt neg symptom mani
doc awar pt w/ neg symptom link
zntl initi zentali co lead asset potenti best-in-class
oral serd treatment metastat breast cancer addit inhibitor zn-
egfr inhibitor develop advanc solid tumor nsclc
libtayo piii trial nsclc met primari endpoint os interim analysi
decreas risk death vs chemo hr os benefit
appear compar pembro show hr similar pt
popul regulatori submiss libtayo expect later year kevzara show
mix data signal clinic benefit detect sever pt
virtual day conduct three kol event virtual day discuss
treatment wamd atop dermat multipl myeloma wamd doc view
faricimab next big drug link atop dermat jak inhibitor might abl
address inadequ efficaci dupi sever patient link myeloma doc think
cart win efficaci like off-the-shelf bcma therapeut commun set
howev think car-t move earlier line cart note late onset
favor factor commerci link
pleas see import disclosur inform page report
chri howerton key report initi buy
expert call trodelvi approv
initi buy avdl
initi acadia buy rate pt co lead drug pimavanserin
pim select yet potent versatil drug w/ remark safeti profil
see pim achiev peak us sale across four indic key-
valu driver dementia-rel psychosi drp give chanc approv
initi buy w/ pt link host confer call
dr suleiman former fda offic focus newli issu form
w/ key topic nature/sever cite observ potenti solut
impact approv decision/timelin likelihood contempl scenario
link immu trodelvi approv well pdufa see remov
prolong uncertainti de-risk entir pipelin given unmet
need robust efficaci adequ prep expect rapid adopt mtnbc link
initi avadel avdl like share base upon opport lead asset
narcolepsi see high likelihood avdl differenti admittedli
sinc initi compani report data complet
success show robust efficaci endpoint result pt increas
read report includ note relat termin pah program
streamlin pipelin focu neuro kidney diseas also summar
discuss w/ kidney doc auph compil
abstract titl relat zlab preview upcom
catalyst mru initi
summari cnce mtg relat ph iii plan alopecia areata
highli read
read note also includ note alni deal w/ bx describ
deal may set path self-sustain note /vir hbv
data potenti readthrough arwr/jnj hbv program publish note
relat impact coverag univers
pleas see import disclosur inform page report
top note past week
pleas see import disclosur inform page report
tickertitled sentiment consist w/ view like ad benefitapril remdesivir data interest impt data week w/ expectationsapril manufactur ramp prepar widespread useapril preview plannerapril detail niaid studi consist effectsapril studi posit hit primari efficaci endpoint earlyapril expert think chanc win appeal year rais pt mix data probabl benefit modest saidapril happen biopharma biz management say impact april quick updat flag court eu regulatori meetingapril call day tidbit alzheim cardio wamd nash moreapril preview guidanc comment realli wood yet april call vaccin developmentapril midst speed-bump court reason appeal pot lapril xbi ibb close break think happeningapril event decis thought go april discuss vaccin developmentapril comment interest chang thesi maintain top-ideaapril ph iii ctd-pah pictur heavi discount look buy opptymarch impact smid-cap coverag w/ pick considerapril shift stori adu timelin shift vs consensusapril data far thought meet w/ management weekapril day takeaway -- kidney session auph april market meet hous hous minapril takeaway nash environ look upcom drugsapril part abstract titl kras-rel zlab april path recoveri requir patienc maintain buyapril pictur type-stock remd covid impact thought guidancemay thought catalyst path yr us/eu patent situat fineapril preview myelofibrosi mru front transfer deal caught w/ management vs long-term dynam stock environmentapril call new gist product develop dcphapril preview factor pozi updat april univers expert call new drug develop gistapril w/ management re-visit pot turnaround cancer trade cashapril w/ blackston help set path self-sustainabilityapril parkinson data mix cheap stock need convict programapril guidanc rais first covid world april spend remd take short-term hit sacrific april come us launch requir patienc view april short interest market capapril univers expert call vaccin developmentapril pt updat zlab sgmoapril get move clinic -- dual moa make senseapril data pralsetinib mtc nda file track take xene crspapril call blu managementapril come w/ fda put defin path first ph iii start mostli straightforward guidanc maintainedapril equiti research
inform compani recommend
report pleas visit websit http //
javatar bluematrix com/sellside/disclosur action call
michael yee certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
biren amin certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
eun yang ph certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
mauri raycroft ph certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
chri howerton phd certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
jefferi llc act financi advisor nightstar therapeut plc announc acquisit biogen inc
jefferi llc act financi advisor kite pharma kite sale compani
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr amarin corpor
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr avadel pharmaceut plc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr biogen inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr blueprint medicin corpor
jefferi group llc make market secur adr
jefferi group llc make market secur adr esperion inc
jefferi group llc make market secur adr fibrogen inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr iovanc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr meru nv
pleas see import disclosur inform page report
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr synlog inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr vertex pharmaceut incorpor
jefferi group llc make market secur adr
jefferi group llc make market secur adr zai lab limit
jefferi group llc make market secur adr inc
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic amarin corpor
within past twelv month amarin corpor client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
amarin corpor one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic aurinia inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
plc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic avadel pharmaceut plc
within past twelv month avadel pharmaceut plc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
plc one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili
pleas see import disclosur inform page report
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
within past twelv month client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
immunomed inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
karyopharm inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
within next three month
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili
within past twelv month client jefferi llc invest bank servic
provid
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic meru nv
within past twelv month meru nv client jefferi llc invest bank servic
pleas see import disclosur inform page report
